Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vismodegib with Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer
NCT00636610Phase 2Completed
- Sponsor
- Genentech
- Start
- May 2008
- Primary completion
- Dec 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of vismodegib in metastatic colorectal cancer (mCRC), sponsored by Genentech. Started May 2008; status: completed.
02
Drugs
vismodegib
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00636610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00636610.